कोरोना का नया वैरिएंट BF.7 भारत के लिए कितनी बड़ी चुनौती है? समझिए CCMB के पूर्व डायरेक्टर और TIGS के डायरेक्टर ड़ॉ. राकेश मिश्रा से.
पूरा वीडियो देखने के लिए लिंक पर क्लिक करें
22Dec
Related Posts
11Jun
A-post-Covid-19 social protection architecture for India,Hindustan Times,11 Jun 2020
https://www.hindustantimes.com/analysis/a-post-covid-19-social-protection-architecture-for-india/story-BCt1POzFojnKloCkHTsv9H.html read more
12Mar
कोरोना के नए वैरिएंट
टाटा इंस्टीट्यूट फॉर जेनेटिक्स एंड सोसाइटी के निदेशक राकेश मिश्रा का कहना... read more
26Dec
On the new recent surge in Covid 19 cases and JN.1 variant
The Tata Institute for Genetics and Society (TIGS) has been conducting sewage... read more
17Aug
Antimicrobial Resistance has become a ‘silent pandemic’
Speaking to The Hindu, Dr. Rakesh Mishra, Director, TIGS highlights the threat... read more
20Oct
Stem Cell technology offers new hope for treating rare genetic disorders
Stem cell technology has witnessed advancement that open new hopes for the... read more
09May
COVID-19 in endemic stage, still need to monitor viral load, new variant: Top expert
Coronavirus is in the endemic stage but the viral load and emergence... read more
07Oct
Delegation visit from Swissnex in India
We were pleased to host a delegation from Swissnex in India to... read more
09Dec
PhD Admissions – List of selected candidates
TIGS PhD admissions (Jan 2023) via AcSIR List of selected candidates Click here Instructions/information for... read more
28Apr
Health expert calls for reducing booster dose gap from 9 to 6 months
Director of Tata Institute for Genetics and Society (TIGS), Bengaluru, Dr Rakesh... read more
28Feb
Student visit – St. Joesph’s College, Bengaluru
A day well spent! On the occasion of National Science Day and Rare... read more